|
AU2007219282A1
|
|
Chemoprotection using amifostine and related compounds
|
|
US7053072B2
|
|
Methods for the administration of amifostine and related compounds
|
|
US2002035093A1
|
|
Methods for the administration of amifostine and related compounds
|
|
US6384259B1
|
|
Stable amorphous amifostine compositions and dosage form
|
|
US6489312B1
|
|
Pharmaceutical formulations comprising aminoalkyl phosphorothioates
|
|
US6239119B1
|
|
Topical administration of amifostine and related compounds
|
|
US6258821B1
|
|
Compositions comprising trimetrexate and methods of their synthesis and use
|
|
US6407278B2
|
|
Stable amorphous amifostine compositions and methods for the preparation and use of the same
|
|
SA471B1
|
|
crystalline amifostine
|
